Morepen Laboratories Q1 FY27: net profit up 425% to ₹56.4 crore, revenue up 34%
Morepen Laboratories (MOREPENLAB) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹570 crore (+34.1% year on year), net profit of ₹56.4 crore (+424.7%), earnings per share of ₹1.03. The company is valued at about ₹7,250 crore.
What happened
In a filing with the NSE on 27 October 2026 at 01:31 PM, Morepen Laboratories (MOREPENLAB) said that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹570 crore (+34.1% year on year), net profit of ₹56.4 crore (+424.7%), earnings per share of ₹1.03.
Company snapshot
Morepen Laboratories is a small-cap company, with a market value of about ₹7,250 crore.
The stock last traded at ₹132.3, against a 52-week range of ₹33.05–₹150.7 (12.2% below the high).
Before this filing the shares had moved +3.0% over the month and +122.4% over three months. Average daily turnover over the last 20 sessions was about ₹170 crore.
Promoters held 35.65% at the end of Q1 FY27. Foreign institutions owned 1.46% and domestic institutions 1.28%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 425 | 10.7 | 0.2 |
| Q2 FY26 | 412 | 40.9 | 0.75 |
| Q3 FY26 | 484 | 27.5 | 0.5 |
| Q4 FY26 | 485 | 15.7 | 0.28 |
| Q1 FY27 | 570 | 56.4 | 1.03 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock gained 21.0% on average the next trading day and was up 23.4% on average after five days (3 filings with price data).
Market-wide, 9,766 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 4 Aug 2026 | Board Meeting Outcome for For Q1 FY 27 Financial Results | +33.5% | +33.4% |
| 4 Aug 2026 | Q1 FY 27 Financial Results | +33.5% | +33.4% |
| 26 May 2026 | Please Find Attached Quarter And Financial Year Ended March 31, 2026… | −3.9% | +3.4% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Morepen Laboratories Q2 Results 2026 - Find Morepen Laboratories Q2 Earnings Result | MOREPENLAB Q2 results
- Morepen Laboratories Limited Estimates – BSE:MOREPENLAB
- Morepen Laboratories wins Himachal Pradesh High Court relief in ₹118 crore GST refund case
- Morepen Laboratories - FIIs raise stakes after two quarters of cuts; 8 stocks rally up to 135% in 3 months
- Morepen Laboratories GST Notice Quashed by Himachal Pradesh HC
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.